Portfolio (Quarterly)
Guide ↗
Fairmount Funds Management LLC
· CIK 0001802528| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | DNTH | DIANTHUS THERAPEUTICS INC | Healthcare | 2,537,191.0 | $212.9M | 15.38% | +400K | +18.7% | $83.92 | +3.1% |
| 2 | ZBIO | ZENAS BIOPHARMA INC | Healthcare | 2,359,025.0 | $46.1M | 3.33% | +150K | +6.8% | $19.55 | -3.0% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%